Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 7/2017

01.03.2017 | Original Article – Clinical Oncology

Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies

verfasst von: Fabio Martinelli, Antonino Ditto, Giorgio Bogani, Mauro Signorelli, Valentina Chiappa, Domenica Lorusso, Edward Haeusler, Francesco Raspagliesi

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate concordance (C) between pre-operative hysteroscopic-directed sampling and final pathology in uterine cancers.

Methods

A retrospective cross-sectional evaluation of prospectively collected data of women who underwent hysterectomy for uterine malignancies and a previous hysteroscopic-guided biopsy was performed. Diagnostic concordance between pre-operative (hysteroscopic biopsy) and postoperative (uterine specimen) histology was evaluated. In endometrioid-endometrial cancers cases Kappa (k) statistics was applied to evaluate agreement for grading (G) between the preoperative and final pathology.

Results

A total 101 hysterectomies for uterine malignancies were evaluated. There were 23 non-endometrioid cancers: 7 serous (C:5/7, 71.4%); 10 carcinosarcomas (C:7/10, 70%, remaining 3 cases only epithelial component diagnosed); 3 clear cell (C:3/3, 100%); 3 sarcomas (C:3/3, 100%). In 78 cases an endometrioid endometrial cancer was found. In 63 cases there was a histological C (63/78, 80.8%) between hysteroscopic-guided biopsy and final pathology, while in 15 cases (19.2%) only hyperplasia (with/without atypia) was found preoperatively. Overall accuracy to detect endometrial cancer was 80.2%. In 50 out of 63 endometrial cancers (79.4%) grading was concordant. The overall level of agreement between preoperative and postoperative grading was “substantial” according to Kappa (k) statistics (k 0.64; 95% CI: 0.449–0.83; p < 0.001), as well as for G1 (0.679; 95% CI: 0.432–0.926; p < 0.001) and G3 (0.774; 94% CI: 0.534–1; p < 0.001), while for G2 (0.531; 95% CI: 0.286–0.777; p < 0.001) it was moderate.

Conclusions

In our series we found an 80% C between pre-operative hysteroscopic-guided biopsy and final pathology, in uterine malignancies. Moreover, hysteroscopic biopsy accurately predicted endometrial cancer in 80% of cases and “substantially” predicted histological grading. Hysteroscopic-guided uterine sampling could be a useful tool to tailor treatment in patients with uterine malignancies.
Literatur
Zurück zum Zitat Bourdel N, Chauvet P, Tognazza E, Pereira B, Botchorishvili R, Canis M. (2016) Sampling in atypical endometrial hyperplasia: which method results in the lowest underestimation of endometrial cancer? A systematic review and meta-analysis. J Minim Invasive Gynecol 23(5):692–701. doi:10.1016/j.jmig.2016.03.017. Epub 2016 Apr 4. ReviewCrossRefPubMed Bourdel N, Chauvet P, Tognazza E, Pereira B, Botchorishvili R, Canis M. (2016) Sampling in atypical endometrial hyperplasia: which method results in the lowest underestimation of endometrial cancer? A systematic review and meta-analysis. J Minim Invasive Gynecol 23(5):692–701. doi:10.​1016/​j.​jmig.​2016.​03.​017. Epub 2016 Apr 4. ReviewCrossRefPubMed
Zurück zum Zitat Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl):2035–2041CrossRefPubMed Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl):2035–2041CrossRefPubMed
Zurück zum Zitat Ditto A, Martinelli F, Bogani G, Papadia A, Lorusso D, Raspagliesi F (2015) Sentinel node mapping using hysteroscopic injection of indocyanine green and laparoscopic near-infrared fluorescence imaging in endometrial cancer staging. J Minim Invasive Gynecol 22(1):132–133. doi:10.1016/j.jmig.2014.08.009 Epub 2014 Aug 15CrossRefPubMed Ditto A, Martinelli F, Bogani G, Papadia A, Lorusso D, Raspagliesi F (2015) Sentinel node mapping using hysteroscopic injection of indocyanine green and laparoscopic near-infrared fluorescence imaging in endometrial cancer staging. J Minim Invasive Gynecol 22(1):132–133. doi:10.​1016/​j.​jmig.​2014.​08.​009 Epub 2014 Aug 15CrossRefPubMed
Zurück zum Zitat Du J, Li Y, Lv S, Wang Q, Sun C, Dong X, He M, Ulain Q, Yuan Y, Tuo X, Batchu N, Song Q, Li Q (2016) Endometrial sampling devices for early diagnosis of endometrial lesions. J Cancer Res Clin Oncol 142(12):2515–2522 ReviewCrossRefPubMedPubMedCentral Du J, Li Y, Lv S, Wang Q, Sun C, Dong X, He M, Ulain Q, Yuan Y, Tuo X, Batchu N, Song Q, Li Q (2016) Endometrial sampling devices for early diagnosis of endometrial lesions. J Cancer Res Clin Oncol 142(12):2515–2522 ReviewCrossRefPubMedPubMedCentral
Zurück zum Zitat Gkrozou F, Dimakopoulos G, Vrekoussis T, Lavasidis L, Koutlas A, Navrozoglou I, Stefos T, Paschopoulos M (2015) Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies. Arch Gynecol Obstet 291(6):1347–1354. doi:10.1007/s00404-014-3585-x Epub 2014 Dec 19CrossRefPubMed Gkrozou F, Dimakopoulos G, Vrekoussis T, Lavasidis L, Koutlas A, Navrozoglou I, Stefos T, Paschopoulos M (2015) Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies. Arch Gynecol Obstet 291(6):1347–1354. doi:10.​1007/​s00404-014-3585-x Epub 2014 Dec 19CrossRefPubMed
Zurück zum Zitat Helpman L, Kupets R, Covens A, Saad RS, Khalifa MA, Ismiil N, Ghorab Z, Dubé V, Nofech-Mozes S (2014) Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer. Br J Cancer 110(3):609–615. doi:10.1038/bjc.2013.766. Epub 2013 Dec 24CrossRefPubMed Helpman L, Kupets R, Covens A, Saad RS, Khalifa MA, Ismiil N, Ghorab Z, Dubé V, Nofech-Mozes S (2014) Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer. Br J Cancer 110(3):609–615. doi:10.​1038/​bjc.​2013.​766. Epub 2013 Dec 24CrossRefPubMed
Zurück zum Zitat Hinchcliff EM, Esselen KM, Watkins JC, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Quade BJ, Muto MG. (2016) The role of endometrial biopsy in the preoperative detection of uterine leiomyosarcoma. J Minim Invasive Gynecol 23(4):567–572. doi:10.1016/j.jmig.2016.01.022. Epub 2016 Feb 4CrossRefPubMed Hinchcliff EM, Esselen KM, Watkins JC, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Quade BJ, Muto MG. (2016) The role of endometrial biopsy in the preoperative detection of uterine leiomyosarcoma. J Minim Invasive Gynecol 23(4):567–572. doi:10.​1016/​j.​jmig.​2016.​01.​022. Epub 2016 Feb 4CrossRefPubMed
Zurück zum Zitat Huang GS, Gebb JS, Einstein MH, Shahabi S, Novetsky AP, Goldberg GL (2007) Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors. Am J Obstet Gynecol 196(3):243.e1-5CrossRefPubMed Huang GS, Gebb JS, Einstein MH, Shahabi S, Novetsky AP, Goldberg GL (2007) Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors. Am J Obstet Gynecol 196(3):243.e1-5CrossRefPubMed
Zurück zum Zitat Kanis MJ, Rahaman J, Moshier EL, Zakashansky K, Chuang L, Kolev V (2016) Detection and correlation of pre-operative, frozen section, and final pathology in high-risk endometrial cancer. Eur J Gynaecol Oncol 37(3):338–341PubMed Kanis MJ, Rahaman J, Moshier EL, Zakashansky K, Chuang L, Kolev V (2016) Detection and correlation of pre-operative, frozen section, and final pathology in high-risk endometrial cancer. Eur J Gynaecol Oncol 37(3):338–341PubMed
Zurück zum Zitat Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136CrossRefPubMed Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136CrossRefPubMed
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174.CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174.CrossRefPubMed
Zurück zum Zitat Martinelli F, Ditto A, Bogani G, Signorelli M, Chiappa V, Lorusso D, Haeusler E, Raspagliesi F. (2017) laparoscopic sentinel node mapping in endometrial cancer after hysteroscopic injection of indocyanine green. J Minim Invasive Gynecol 24(1):89–93. doi:10.1016/j.jmig.2016.09.020.CrossRefPubMed Martinelli F, Ditto A, Bogani G, Signorelli M, Chiappa V, Lorusso D, Haeusler E, Raspagliesi F. (2017) laparoscopic sentinel node mapping in endometrial cancer after hysteroscopic injection of indocyanine green. J Minim Invasive Gynecol 24(1):89–93. doi:10.​1016/​j.​jmig.​2016.​09.​020.CrossRefPubMed
Zurück zum Zitat Panici PB, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707–1716CrossRef Panici PB, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707–1716CrossRef
Zurück zum Zitat Solima E, Martinelli F, Ditto A, Maccauro M, Carcangiu M, Mariani L, Kusamura S, Fontanelli R, Grijuela B, Raspagliesi F (2012) Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled trcer. Gynecol Oncol 126(3):419–423. doi:10.1016/j.ygyno.2012.05.025. Epub 2012 May 30CrossRefPubMed Solima E, Martinelli F, Ditto A, Maccauro M, Carcangiu M, Mariani L, Kusamura S, Fontanelli R, Grijuela B, Raspagliesi F (2012) Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled trcer. Gynecol Oncol 126(3):419–423. doi:10.​1016/​j.​ygyno.​2012.​05.​025. Epub 2012 May 30CrossRefPubMed
Zurück zum Zitat van Hanegem N, Prins MM, Bongers MY, Opmeer BC, Sahota DS, Mol BW, Timmermans A (2016) The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 197:147–155. doi:10.1016/j.ejogrb.2015.12.008. Epub 2015 Dec 19CrossRefPubMed van Hanegem N, Prins MM, Bongers MY, Opmeer BC, Sahota DS, Mol BW, Timmermans A (2016) The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 197:147–155. doi:10.​1016/​j.​ejogrb.​2015.​12.​008. Epub 2015 Dec 19CrossRefPubMed
Metadaten
Titel
Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies
verfasst von
Fabio Martinelli
Antonino Ditto
Giorgio Bogani
Mauro Signorelli
Valentina Chiappa
Domenica Lorusso
Edward Haeusler
Francesco Raspagliesi
Publikationsdatum
01.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2371-0

Weitere Artikel der Ausgabe 7/2017

Journal of Cancer Research and Clinical Oncology 7/2017 Zur Ausgabe

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.